Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
12/14/2022 | Lucira Health, Inc. | LHDX | Other (disposition) | Common Stock | 3.5M | $0.00 | $0 | | 12/14/2022 |
12/14/2022 | Lucira Health, Inc. | LHDX | Other (disposition) | Common Stock | 3.8M | $0.00 | $0 | | 12/14/2022 |
12/14/2022 | Lucira Health, Inc. | LHDX | Other (disposition) | Common Stock | 5.2M | $0.00 | $0 | | 12/14/2022 |
12/14/2022 | Lucira Health, Inc. | LHDX | Other (disposition) | Common Stock | 735.5k | $0.00 | $0 | | 12/14/2022 |
12/14/2022 | Lucira Health, Inc. | LHDX | Other (acquisition) | Common Stock | 256.7k | $0.00 | $0 | See Footnote | 12/14/2022 |
12/14/2022 | Lucira Health, Inc. | LHDX | Other (acquisition) | Common Stock | 725.7k | $0.00 | $0 | See Footnotes | 12/14/2022 |
05/13/2022 | Applied Molecular Transport Inc. | AMTI | Purchase | Common Stock | 29.8k | $4.17 | $124.1k | See Footnotes | 05/12/2022 |
05/12/2022 | Applied Molecular Transport Inc. | AMTI | Purchase | Common Stock | 32.4k | $3.88 | $125.6k | See Footnotes | 05/12/2022 |
11/17/2021 | Applied Molecular Transport Inc. | AMTI | Purchase | Common Stock | 7.1k | $22.38 | $159.7k | See Footnotes | 11/16/2021 |
11/16/2021 | Applied Molecular Transport Inc. | AMTI | Purchase | Common Stock | 4k | $22.57 | $90.3k | See Footnotes | 11/16/2021 |
02/05/2021 | Lucira Health, Inc. | LHDX | Conversion | 2020B Convertible Promissory Note | 735.5k | $17.00 | $12.5M | | 02/05/2021 |
02/05/2021 | Lucira Health, Inc. | LHDX | Conversion | Series C Convertible Preferred | 5.2M | $0.00 | $0 | | 02/05/2021 |
02/05/2021 | Lucira Health, Inc. | LHDX | Conversion | Series B Convertible Preferred | 3.8M | $0.00 | $0 | | 02/05/2021 |
02/05/2021 | Lucira Health, Inc. | LHDX | Conversion | Series B Convertible Preferred | 32.2k | $0.00 | $0 | | 02/05/2021 |
02/05/2021 | Lucira Health, Inc. | LHDX | Purchase | Common Stock | 3.5M | $17.00 | $58.8M | | 02/05/2021 |
02/05/2021 | Lucira Health, Inc. | LHDX | Conversion | Common Stock | 735.5k | $17.00 | $12.5M | | 02/05/2021 |
02/05/2021 | Lucira Health, Inc. | LHDX | Conversion | Common Stock | 5.2M | $0.00 | $0 | | 02/05/2021 |
02/05/2021 | Lucira Health, Inc. | LHDX | Conversion | Common Stock | 3.8M | $0.00 | $0 | | 02/05/2021 |
02/05/2021 | Lucira Health, Inc. | LHDX | Conversion | Common Stock | 32.2k | $0.00 | $0 | | 02/05/2021 |
06/12/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 2.4k | $44.06 | $107.5k | By Mr. Boeding as Trustee of the Boeding Family Trust | 06/11/2020 |
06/11/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 6.6k | $44.32 | $292.5k | By Mr. Boeding as Trustee of the Boeding Family Trust | 06/11/2020 |
06/09/2020 | Applied Molecular Transport Inc. | AMTI | Conversion | Common Stock | 2.1M | $0.00 | $0 | See footnotes | 06/09/2020 |
06/09/2020 | Applied Molecular Transport Inc. | AMTI | Conversion | Common Stock | 3.4M | $0.00 | $0 | See footnotes | 06/09/2020 |
06/09/2020 | Applied Molecular Transport Inc. | AMTI | Purchase | Common Stock | 2.5M | $14.00 | $35M | See footnotes | 06/09/2020 |
06/09/2020 | Applied Molecular Transport Inc. | AMTI | Purchase | Common Stock | 220k | $14.00 | $3.1M | See footnotes | 06/09/2020 |
06/09/2020 | Applied Molecular Transport Inc. | AMTI | Conversion | Series B Preferred Stock | 2.1M | $0.00 | $0 | See footnotes | 06/09/2020 |
06/09/2020 | Applied Molecular Transport Inc. | AMTI | Conversion | Series C Preferred Stock | 3.4M | $0.00 | $0 | See footnotes | 06/09/2020 |
05/22/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 2.1k | $55.90 | $116.6k | By Mr. Boeding as Trustee for the Boeding Family Trust | 05/09/2019 |
05/21/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 520 | $55.80 | $29k | By Mr. Boeding as Trustee for the Boeding Family Trust | 05/09/2019 |
05/20/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 5.7k | $58.00 | $328.7k | By Mr. Boeding as Trustee for the Boeding Family Trust | 05/09/2019 |
05/20/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 417 | $57.22 | $23.9k | By Mr. Boeding as Trustee for the Boeding Family Trust | 05/09/2019 |
01/29/2020 | Quince Therapeutics, Inc. | CRTX | Other (disposition) | Common Stock | 4.3k | $54.30 | $235.6k | By Mr. Boeding as Trustee for the Mitsou Peterson-Cushing 2019 Irrevocable Trust | 05/09/2019 |
08/21/2019 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 1.6k | $24.87 | $40.7k | | 05/09/2019 |
08/21/2019 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 420 | $24.87 | $10.4k | By Mr. Boeding as Trustee of Boeding Family Trust | 05/09/2019 |
08/21/2019 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 420 | $24.87 | $10.4k | By Mr. Boeding as Trustee of Boeding Family Trust | 05/09/2019 |
|